A Study of PEG-somatropin in the Treatment of Children With Idiopathic Short Stature
Condition: Dwarfism Interventions: Drug: Jintrolong® low dose group; Drug: Jintrolong® high dose group Sponsors: GeneScience Pharmaceuticals Co., Ltd.; Tongji Hospital; First Hospital of Jilin University; Affiliated Hospital of Jiangnan University; The First Affiliated Hospital with Nanjing Medical University; Shanghai Children's Hospital; The Children's Hospital of Zhejiang University School of Medicine; Children's Hospital of Fudan University Recruiting - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 14, 2017 Category: Research Source Type: clinical trials
A Study of PEG-somatropin Injection to Treat Children of Turner Syndrome
Condition: Turner Syndrome Interventions: Biological: PEG-rhGH low dose; Biological: PEG-rhGH high dose; Other: Non-treatment control group Sponsors: GeneScience Pharmaceuticals Co., Ltd.; Beijing Children's Hospital; The First Affiliated Hospital with Nanjing Medical University; Shanghai Children's Hospital; Children's Hospital of Fudan University; Xinhua Hospital, Shanghai Jiao Tong University School of Medicine; First Hospital of Jilin University; Jiangxi Province Children's Hospital; Affiliated Hospital of Jiangnan University; The Children's Hosp...
Source: ClinicalTrials.gov - June 13, 2017 Category: Research Source Type: clinical trials
